A study of people with HIV and hepatitis C co-infection finds that limited access to food is associated with higher levels of HIV in the blood and 10% fewer CD4+ immune cells.
As one of the few global health threats with easy solutions, why aren't we seeing an impact on the viral hepatitis epidemic?
According to a new Swiss study, uptake of anti-hepatitis C therapy by people coinfected with HIV rose dramatically with the advent of direct-acting antivirals (DAAs), especially second-generation DAAs.
The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.
"There are many interrelated epidemics within the 'opioid syndemic,'" Thomas J. Stopka writes. "Together, they make up perhaps the biggest public health challenge in the U.S. since the advent of the AIDS epidemic."
"Many of us rightly focus on testing, surveillance and linkage to care," Matthew Zielske writes. "Education often comes as an addendum to any of these things, but hardly ever stands alone."
The opioid crisis is causing a surge in the number of hepatitis C cases among young people.
"Like it or not, if we are ever going to eliminate hepatitis C, we are going to have to test and treat prisoners," Alan Franciscus writes.
New York Study Finds Almost Half of HIV-Positive Gay Men Co-Infected With Hepatitis C Have Detectable Levels of Hepatitis C Virus in Their Rectal Fluid
Researchers have found levels of hepatitis C virus in the rectal fluid of HIV-positive MSM co-infected with hepatitis C that are high enough for hepatitis C transmission to occur through condomless anal sex.